How much does one injection of Alemtuzumab cost?

Alemtuzumab is a monoclonal antibody drug used to treat certain types of blood cancers and autoimmune diseases. The uniqueness of this drug lies in its mechanism and its wide range of applications.

Alemtuzumab is not currently on the market in China, so patients cannot purchase it domestically. There are only original French drugs available abroad, and one shot costs around 100,000 yuan.

Alemtuzumab was originally developed to treat chronic lymphocytic leukemia (CLL). Its mechanism of action is through targeted inhibition of the expression of CD52 antigen, which is widely present on the surface of lymphocytes. Alemtuzumab can reduce the symptoms of leukemia by prompting the immune system to attack and eliminate abnormally proliferating lymphocytes.

In addition to being used to treat CLL, alemtuzumab is also used to treat a variety of autoimmune diseases, such as multiple sclerosis (MS) and rheumatoid arthritis (RA). In these cases, alemtuzumab works by resetting the immune system to reduce attacks on your own tissues. This "reset"of the immune system helps reduce disease symptoms and control its progression.

However, the use of alemtuzumab may cause some side effects, including an increased risk of infection and autoimmune reactions. Therefore, the patient's disease and medical history, as well as the potential risks and benefits, must be carefully evaluated before use.

In summary, alemtuzumab is an important therapeutic tool for a variety of blood cancers and autoimmune diseases. Its mechanism is through the intervention of the immune system, aiming to improve the patient's quality of life and treat the disease. However, its use must be under the guidance of a medical professional to ensure optimal results and minimal risks.